Stock Scorecard
Stock Summary for Amneal Pharmaceuticals Inc - Class A (AMRX) - $8.42 as of 7/4/2025 12:31:19 AM EST
Total Score
4 out of 30
Safety Score
35 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for AMRX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AMRX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AMRX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for AMRX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for AMRX (35 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for AMRX
Financial Details for AMRX
Company Overview |
|
|---|---|
| Ticker | AMRX |
| Company Name | Amneal Pharmaceuticals Inc - Class A |
| Country | USA |
| Description | Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company is headquartered in Bridgewater, New Jersey. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 8/7/2025 |
Stock Price History |
|
| Last Day Price | 8.42 |
| Price 4 Years Ago | 4.79 |
| Last Day Price Updated | 7/4/2025 12:31:19 AM EST |
| Last Day Volume | 898,793 |
| Average Daily Volume | 1,753,506 |
| 52-Week High | 9.47 |
| 52-Week Low | 6.50 |
| Last Price to 52 Week Low | 29.54% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.93 |
| Sector PE | 40.90 |
| 5-Year Average PE | 14.06 |
| Free Cash Flow Ratio | 44.32 |
| Industry Free Cash Flow Ratio | 17.71 |
| Sector Free Cash Flow Ratio | 32.91 |
| Current Ratio Most Recent Quarter | 1.40 |
| Total Cash Per Share | 0.19 |
| Book Value Per Share Most Recent Quarter | -0.42 |
| Price to Book Ratio | 86.10 |
| Industry Price to Book Ratio | 34.53 |
| Sector Price to Book Ratio | 30.76 |
| Price to Sales Ratio Twelve Trailing Months | 1.38 |
| Industry Price to Sales Ratio Twelve Trailing Months | 121.97 |
| Sector Price to Sales Ratio Twelve Trailing Months | 35.60 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 313,420,000 |
| Market Capitalization | 2,638,996,400 |
| Institutional Ownership | 44.24% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -75.00% |
| Annual Earnings Growth | -39.16% |
| Reported EPS 12 Trailing Months | -0.04 |
| Reported EPS Past Year | 0.21 |
| Reported EPS Prior Year | 0.58 |
| Net Income Twelve Trailing Months | -13,048,000 |
| Net Income Past Year | -116,886,000 |
| Net Income Prior Year | -83,993,000 |
| Quarterly Revenue Growth YOY | 5.50% |
| 5-Year Revenue Growth | 11.43% |
| Operating Margin Twelve Trailing Months | 14.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 59,187,000 |
| Total Cash Past Year | 110,552,000 |
| Total Cash Prior Year | 91,542,000 |
| Net Cash Position Most Recent Quarter | -2,094,792,000 |
| Net Cash Position Past Year | -2,051,238,000 |
| Long Term Debt Past Year | 2,161,790,000 |
| Long Term Debt Prior Year | 2,427,451,000 |
| Total Debt Most Recent Quarter | 2,153,979,000 |
| Equity to Debt Ratio Past Year | -0.05 |
| Equity to Debt Ratio Most Recent Quarter | 0.32 |
| Total Stockholder Equity Past Year | -109,267,000 |
| Total Stockholder Equity Prior Year | 19,781,000 |
| Total Stockholder Equity Most Recent Quarter | 1,016,435,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 238,525,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.76 |
| Free Cash Flow Past Year | 243,175,000 |
| Free Cash Flow Prior Year | 276,388,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.19 |
| MACD Signal | 0.16 |
| 20-Day Bollinger Lower Band | 6.76 |
| 20-Day Bollinger Middle Band | 7.88 |
| 20-Day Bollinger Upper Band | 8.99 |
| Beta | 1.06 |
| RSI | 66.19 |
| 50-Day SMA | 8.05 |
| 150-Day SMA | 5.21 |
| 200-Day SMA | 4.97 |
System |
|
| Modified | 7/4/2025 12:42:30 AM EST |